Metabolic & Incretin Signaling99%+purityLab verifiedon every lotResearch use only·Third-party verified·99%+ HPLC Purity.
Metabolic & Incretin Signaling
TRZ
Dual GIP and GLP-1 receptor co-agonist
TRZ activates both GIP and GLP-1 receptor pathways, synergistically driving insulin secretion, modulating glucagon dynamics, and promoting negative energy balance in metabolic research models.
Know exactly what’s in the vial.
How it works
- Activates both GIP and GLP-1 receptor pathways, synergistically driving insulin secretion.
- Modulates pancreatic glucagon dynamics and enhances peripheral insulin responsiveness.
- Delays gastric emptying rate in preclinical models, moderating postprandial glucose excursions.
- Stimulates central hypothalamic pro-opiomelanocortin (POMC) neurons to signal satiety.
Where it shines
- Metabolic syndrome, insulin sensitivity, and glycemic control research models.
- Adipose tissue lipolysis and substrate partitioning kinetic assays.
- Comparative studies against selective single-agonist incretin analogs.
The specs, on the record
Stability & storage
- Lyophilized powder - store at -20°C, protected from light.
- Reconstituted - refrigerate at 2-8°C; use within ~30 days.
- Avoid thermal agitation and repeated freeze-thaw cycles.
Backed by the science
The receipts. Peer-reviewed.
Every citation above is real, public, and linked. Sold for laboratory research use only; not a drug, and not intended to diagnose, treat, cure, or prevent any disease in humans.
Metabolic & Incretin Signaling
Researchers often pair BPC-157 with

The canonical co-studied tissue-repair pair - cytoprotective signaling alongside actin-regulated cell migration.

Copper-peptide ECM / collagen-remodeling research sits in the same repair axis.

BPC-157 is one of three peptides in the GLOW research stack - the consolidated repair + dermal kit.